Sarah L. Pogue

Person

Frazer, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Combination of lenalidomide and polypeptide construct, and uses the...
- Patent number 11,253,591
- Issue date Feb 22, 2022
- Teva Pharmaceuticals Australia Pty Ltd.
- Sarah L. Pogue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
- Patent number 11,117,975
- Issue date Sep 14, 2021
- Teva Pharmaceuticals Australia Pty Ltd.
- Adam Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusions of antibodies to CD38 and attenuated interferon alpha
- Patent number 10,981,986
- Issue date Apr 20, 2021
- Teva Pharmaceuticals Australia Pty Ltd.
- David S. Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of lenalidomide and polypeptide construct, and uses the...
- Patent number 10,232,041
- Issue date Mar 19, 2019
- TEVA PHARMACEUTICALS PTY LTD
- Sarah L. Pogue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
- Patent number 9,963,515
- Issue date May 8, 2018
- Teva Pharmaceuticals Australia Pty Ltd.
- Adam Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies
- Patent number 9,932,411
- Issue date Apr 3, 2018
- Oxford BioTherapeutics Ltd.
- Jonathan Alexander Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of lenalidomide and polypeptide construct, and uses the...
- Patent number 9,636,334
- Issue date May 2, 2017
- Teva Pharmaceuticals Australia Pty Ltd
- Sarah L. Pogue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusions of antibodies to CD38 and attenuated interferon alpha
- Patent number 9,611,322
- Issue date Apr 4, 2017
- Teva Pharmaceuticals Australia Pty Ltd
- David S. Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)
- Patent number 8,758,757
- Issue date Jun 24, 2014
- Medarex, L.L.C.
- Josephine M. Cardarelli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies against stromal derived factor-1 (SDF-1)
- Patent number 8,496,931
- Issue date Jul 30, 2013
- Medarex, Inc.
- Sarah L. Pogue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies that bind mesothelin, and uses thereof
- Patent number 8,425,904
- Issue date Apr 23, 2013
- Bristol-Myers Squibb Company
- Jonathan A. Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies that bind mesothelin, and uses thereof
- Patent number 8,399,623
- Issue date Mar 19, 2013
- Bristol-Myers Squibb Company
- Jonathan A. Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies that bind mesothelin, and uses thereof
- Patent number 8,383,779
- Issue date Feb 26, 2013
- Bristol-Myers Squibb Company
- Jonathan A. Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies that bind mesothelin, and uses thereof
- Patent number 8,268,970
- Issue date Sep 18, 2012
- Bristol-Myers Squibb Company
- Jonathan A. Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)
- Patent number 7,888,484
- Issue date Feb 15, 2011
- Medarex, Inc.
- Josephine M. Cardarelli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)
- Patent number 7,619,070
- Issue date Nov 17, 2009
- Medarex, Inc.
- Josephine M. Cardarelli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-CD47 COMBINATION THERAPY
- Publication number 20220259311
- Publication date Aug 18, 2022
- TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
- Sarah Lee Pogue
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD47 COMBINATION THERAPY
- Publication number 20200010544
- Publication date Jan 9, 2020
- TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
- Sarah Lee POGUE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF LENALIDOMIDE AND POLYPEPTIDE CONSTRUCT, AND USES THE...
- Publication number 20190151447
- Publication date May 23, 2019
- Teva Pharmaceuticals Australia Pty Ltd
- Sarah L. Pogue
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B
- Publication number 20180305460
- Publication date Oct 25, 2018
- Teva Pharmaceuticals Australia Pty Ltd
- Adam Clarke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSIONS OF ANTIBODIES TO CD38 AND ATTENUATED INTERFERON ALPHA
- Publication number 20170233449
- Publication date Aug 17, 2017
- Teva Pharmaceuticals Australia Pty Ltd
- David S. Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF LENALIDOMIDE AND POLYPEPTIDE CONSTRUCT, AND USES THE...
- Publication number 20170202962
- Publication date Jul 20, 2017
- Teva Pharmaceuticals Australia Pty Ltd
- Sarah L. Pogue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYPEPTIDE CONSTRUCTS AND USES THEREOF
- Publication number 20160367695
- Publication date Dec 22, 2016
- Teva Pharmaceuticals Australia Pty Ltd
- David S. Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES ANTI MATRIPTASE FOR THE TREATMENT OF CANCER
- Publication number 20160289338
- Publication date Oct 6, 2016
- OXFORD BIOTHERAPEUTICS LTD
- Jonathan Alexander TERRETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B
- Publication number 20160068612
- Publication date Mar 10, 2016
- Teva Pharmaceuticals Australia Pty Ltd
- Adam Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination of Lenalidomide and Polypeptide Construct, and Uses The...
- Publication number 20150313965
- Publication date Nov 5, 2015
- Teva Pharmaceuticals Australia Pty, Ltd
- Sarah L. Pogue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYPEPTIDE CONSTRUCTS AND USES THEREOF
- Publication number 20140248238
- Publication date Sep 4, 2014
- Teva Pharmaceuticals Australia Pty Ltd
- David S. Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN ANTIBODIES THAT BIND MESOTHELIN, AND USES THEREOF
- Publication number 20130190481
- Publication date Jul 25, 2013
- Bristol-Myers Squibb Company
- Jonathan A. Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODIES THAT BIND MESOTHELIN, AND USES THEREOF
- Publication number 20130028904
- Publication date Jan 31, 2013
- Bristol -Myers Squibb Company
- Jonathan A. Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODIES THAT BIND MESOTHELIN, AND USES THEREOF
- Publication number 20130028905
- Publication date Jan 31, 2013
- Bristol -Myers Squibb Company
- Jonathan A. Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODIES THAT BIND MESOTHELIN, AND USES THEREOF
- Publication number 20130028906
- Publication date Jan 31, 2013
- Bristol -Myers Squibb Company
- Jonathan A. Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODIES THAT BIND MESOTHELIN, AND USES THEREOF
- Publication number 20110262448
- Publication date Oct 27, 2011
- Bristol-Myers Squibb Company
- Jonathan A. TERRETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTIBODIES TO INTERFERON ALPHA RECEPTOR-1 (IFNAR-1)
- Publication number 20110086422
- Publication date Apr 14, 2011
- Josephine M. Cardarelli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST STROMAL DERIVED FACTOR-1 (SDF-1)
- Publication number 20100158902
- Publication date Jun 24, 2010
- ONO PHARMACEUTICAL CO., LTD.
- Sarah L. Pogue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTIBODIES TO INTERFERON ALPHA RECEPTOR-1 (IFNAR-1)
- Publication number 20100104569
- Publication date Apr 29, 2010
- Medarex, Inc.
- Josephine M. Cardarelli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)
- Publication number 20050208041
- Publication date Sep 22, 2005
- Medarex, Inc.
- Josephine M. Cardarelli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Sarah L. Pogue

Person

Patents Grantslast 30 patents

Combination of lenalidomide and polypeptide construct, and uses the...

Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B

Fusions of antibodies to CD38 and attenuated interferon alpha

Combination of lenalidomide and polypeptide construct, and uses the...

Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B

Antibodies

Combination of lenalidomide and polypeptide construct, and uses the...

Fusions of antibodies to CD38 and attenuated interferon alpha

Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)

Monoclonal antibodies against stromal derived factor-1 (SDF-1)

Human antibodies that bind mesothelin, and uses thereof

Human antibodies that bind mesothelin, and uses thereof

Human antibodies that bind mesothelin, and uses thereof

Human antibodies that bind mesothelin, and uses thereof

Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)

Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)

Patents Applicationslast 30 patents

ANTI-CD47 COMBINATION THERAPY

ANTI-CD47 COMBINATION THERAPY

COMBINATION OF LENALIDOMIDE AND POLYPEPTIDE CONSTRUCT, AND USES THE...

ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B

FUSIONS OF ANTIBODIES TO CD38 AND ATTENUATED INTERFERON ALPHA

COMBINATION OF LENALIDOMIDE AND POLYPEPTIDE CONSTRUCT, AND USES THE...

POLYPEPTIDE CONSTRUCTS AND USES THEREOF

ANTIBODIES ANTI MATRIPTASE FOR THE TREATMENT OF CANCER

ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B

Combination of Lenalidomide and Polypeptide Construct, and Uses The...

POLYPEPTIDE CONSTRUCTS AND USES THEREOF

HUMAN ANTIBODIES THAT BIND MESOTHELIN, AND USES THEREOF

HUMAN ANTIBODIES THAT BIND MESOTHELIN, AND USES THEREOF

HUMAN ANTIBODIES THAT BIND MESOTHELIN, AND USES THEREOF

HUMAN ANTIBODIES THAT BIND MESOTHELIN, AND USES THEREOF

HUMAN ANTIBODIES THAT BIND MESOTHELIN, AND USES THEREOF

HUMANIZED ANTIBODIES TO INTERFERON ALPHA RECEPTOR-1 (IFNAR-1)

MONOCLONAL ANTIBODIES AGAINST STROMAL DERIVED FACTOR-1 (SDF-1)

HUMANIZED ANTIBODIES TO INTERFERON ALPHA RECEPTOR-1 (IFNAR-1)

Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)